The objective of this original research was to evaluate the expression of Trop-2 in EOC tissues and primary cell lines and to examine the preclinical anti-tumor activity of SG in vitro and in vivo against multiple primary EOC models and xenografts. Here, TACSTD2 is linked to neoplasm.